What does a Treponema pallidum hemagglutination assay (TPHA) result of 0.01 mean?

TPHA 0.01 — How to interpret

Bold recommendation: A TPHA value reported as 0.01 is best interpreted as nonreactive/negative (no serologic evidence of syphilis), but syphilis cannot be excluded without a paired nontreponemal test (RPR/VDRL) and clinical context. 1, 2

• What TPHA measures:

  • TPHA (a treponemal test, same class as TP-PA/TPPA) detects antibodies specific to Treponema pallidum; results are typically qualitative (reactive/nonreactive) with titers if reactive. Treponemal titers do not reflect disease activity and are not used to monitor treatment. 3

• Why “0.01” likely means negative:

  • Labs sometimes output an index/OD; very low values (e.g., 0.01) fall below the reactive cutoff and are treated as nonreactive. Treponemal tests alone cannot diagnose or exclude syphilis; algorithms require BOTH a treponemal and a nontreponemal test. 1, 2

• Action algorithm (prioritizing morbidity, mortality, and QoL):

  1. If TPHA 0.01 and NO symptoms/risk in the last 90 days:
     • Interpret as negative; no further testing needed unless new risk. Document baseline. 1, 2
  2. If TPHA 0.01 but recent exposure (<90 days), chancre, rash on palms/soles, uveitis, meningitic symptoms, or pregnancy:
     • Obtain a quantitative nontreponemal test (RPR or VDRL) now and repeat serology in 2–4 weeks if suspicion persists; consider lesion PCR if ulcer present. Early infection can be seronegative; missing early syphilis risks transmission, adverse pregnancy outcomes, and neurosyphilis. 1, 4, 3
  3. If prior treated syphilis:
     • A nonreactive TPHA is uncommon after the primary stage but can occur; rely on documented history and monitor with quantitative RPR/VDRL if treatment response is in question. Do not use treponemal titers to gauge response. 3
  4. If treponemal-first lab algorithm used and TPHA is the screen:
     • With nonreactive TPHA, no further testing is usually required. If clinical suspicion is high, add RPR/VDRL or repeat in 1–2 weeks to avoid missed very-early infection. 1, 2

• Pitfalls and caveats:

  • Do not “rule out” early syphilis on a single negative treponemal test; repeat or add RPR/VDRL if symptoms/recent risk. 1
  • Treponemal tests may stay reactive for life after infection; they do not track activity—use RPR/VDRL titers for treatment response. 3
  • Rare atypical serology can occur in HIV; when discordant, repeat testing and consider direct detection (PCR) from lesions. 5, 1

• Why this recommendation:

  • Most recent, highest-quality guidance (CDC 2024 laboratory recommendations) mandates dual-test algorithms and cautions against interpreting a single treponemal result in isolation, to prevent missed early disease and its complications. 1
  • Longstanding CDC guidance affirms treponemal tests are poor markers of activity and must be paired with nontreponemal testing. 3, 2